サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：軟部組織同種移植片市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
市場調査レポート
商品コード
1140623

軟部組織同種移植片市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）

Soft Tissue Allografts Market (Product Type: Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Collagen Allografts, and Amniotic Allografts) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
軟部組織同種移植片市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年08月09日
発行: Transparency Market Research
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の軟部組織同種移植片市場について調査し、市場の概要とともに、2022年～2031年の予測、製品別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー：世界の軟部組織同種移植片市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の軟部組織同種移植片市場の分析と予測、2017年～2031年

第5章 主な洞察

  • 主な合併と買収
  • 技術の進歩
  • COVID-19の影響分析

第6章 世界の軟部組織同種移植片市場の分析と予測、製品別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、製品別、2017年～2031年
    • 軟骨同種移植片
    • 腱同種移植片
    • 歯科同種移植片
    • 半月板同種移植片
    • コラーゲン同種移植片
    • 羊膜同種移植片
  • 製品別の市場魅力分析

第7章 世界の軟部組織同種移植片市場の分析と予測、用途別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、用途別、2017年～2031年
    • 整形外科
    • 歯科
    • 創傷ケア
    • その他
  • 用途別の市場魅力分析

第8章 世界の軟組織同種移植片市場の分析と予測、エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場価値予測、エンドユーザー別、2017年～2031年
    • 整形外科クリニック
    • 歯科医院
    • 外来手術センター
    • 美容センター
  • エンドユーザー別の市場魅力分析

第9章 世界の軟部組織同種移植片市場の分析と予測、地域別

  • 主な調査結果
  • 市場価値予測、地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 地域別の市場魅力分析

第10章 北米の軟部組織同種移植片市場の分析と予測

第11章 欧州の軟部組織同種移植片市場の分析と予測

第12章 アジア太平洋の軟部組織同種移植片市場の分析と予測

第13章 ラテンアメリカの軟部組織同種移植片市場の分析と予測

第14章 中東・アフリカの軟部組織同種移植片市場の分析と予測

第15章 競合情勢

  • 市場参入企業-競合マトリクス（層および企業規模別）
  • 市場シェア分析、企業別、2021年
  • 企業プロファイル
    • Lattice Biologics Ltd
    • Zimmer Biomet
    • AlonSource Group
    • MiMedix Group.
    • AlloSource.
    • CONMED Corporation.
    • Organogenesis, Inc.
    • RTI Surgical, Inc.
    • Osiris Therapeutics.
    • Integra LifeSciences Corporation.
    • Globus Medical, Inc.
    • B. Braun Melsungen AG.
    • Arthrex
図表

List of Tables

  • Table 01: Global Soft Tissue Allografts Market Pipeline Analysis
  • Table 02: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 03: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 04: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Region, 2022-2031
  • Table 05: North America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country, 2022-2031
  • Table 06: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 07: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 08: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022-2031
  • Table 09: Europe Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 10: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 11: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 12: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user,2022-2031
  • Table 13: Asia Pacific Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 14: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 15: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 16: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022-2031
  • Table 17: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 18: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 19: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 20: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022-2031
  • Table 21: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
  • Table 22: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022-2031
  • Table 23: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022-2031
  • Table 24: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022-2031

List of Figures

  • Figure 01: Global Soft Tissue Allografts Market (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031
  • Figure 03: Global Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 04: Global Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 05: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Product Type, 2017-2031
  • Figure 06: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Application, 2017-2031
  • Figure 07: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2017-2031
  • Figure 08: North America Soft Tissue Allografts Market (US$ Mn) Forecast, 2017-2031
  • Figure 09: North America Soft Tissue Allografts Market Share Analysis, by Country, 2021 and 2031
  • Figure 10: North America Soft Tissue Allografts Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 11: North America Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031
  • Figure 12: North America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 13: North America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 14: North America Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 15: North America Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 16: North America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 17: Europe Soft Tissue Allografts Market(US$ Mn) Forecast, 2017-2031
  • Figure 18: Europe Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 19: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 20: Europe Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031
  • Figure 21: Europe Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 22: Europe Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 23: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 24: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 25: Europe Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 26: Asia Pacific Soft Tissue Allografts Market(US$ Mn) Forecast, 2017-2031
  • Figure 27: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 28: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 29: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031
  • Figure 30: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 31: Asia Pacific Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 32: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 33: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 34: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 35: Latin America Soft Tissue Allografts Market(US$ Mn) Forecast, 2017-2031
  • Figure 36: Latin America Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 37: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 38: Latin America Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031
  • Figure 39: Latin America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 40: Latin America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 41: Latin America Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 42: Latin America Tissue Allografts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 43: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 44: Middle East & Africa Soft Tissue Allografts Market(US$ Mn) Forecast, 2017-2031
  • Figure 45: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 46: Middle East & Africa Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 46: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031
  • Figure 47: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031
  • Figure 48: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031
  • Figure 49: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022-2031
  • Figure 50: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 51: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL12275

The report provides revenue of the global soft tissue allografts market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global soft tissue allografts market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the soft tissue allografts market.

The report delves into the competitive landscape of the global soft tissue allografts market. Key players operating in the global soft tissue allografts market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global soft tissue allografts market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Soft Tissue Allografts Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Soft Tissue Allografts Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Technological Advancements
  • 5.3. COVID-19 Impact Analysis

6. Global Soft Tissue Allografts Market Analysis and Forecast, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Cartilage Allografts
      • 6.3.1.1. Hyaline Cartilage
      • 6.3.1.2. Elastic Cartilage
      • 6.3.1.3. Fibro Cartilage
    • 6.3.2. Tendon Allografts
      • 6.3.2.1. Achilles Tendon
      • 6.3.2.2. Tibialis
      • 6.3.2.3. Patellar Tendon
      • 6.3.2.4. Hamstring
    • 6.3.3. Dental Allografts
      • 6.3.3.1. Free Gingival Graft
      • 6.3.3.2. Connective Tissue Graft
      • 6.3.3.3. Pedicle Graft
    • 6.3.4. Meniscus Allografts
    • 6.3.5. Collagen Allografts
    • 6.3.6. Amniotic Allografts
  • 6.4. Market Attractiveness Analysis, By Product

7. Global Soft Tissue Allografts Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Orthopedics
      • 7.3.1.1. Sports Medicine
      • 7.3.1.2. Spine Surgeries
      • 7.3.1.3. General Orthopedics
      • 7.3.1.4. Reconstruction
    • 7.3.2. Dentistry
      • 7.3.2.1. Dental Sensitivity
      • 7.3.2.2. Aesthetics
    • 7.3.3. Wound Care
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, By Application

8. Global Soft Tissue Allografts Market Analysis and Forecast, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Orthopedic Clinics
    • 8.3.2. Dental Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Aesthetic Centers
  • 8.4. Market Attractiveness Analysis, By End-user

9. Global Soft Tissue Allografts Market Analysis and Forecast, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, By Region

10. North America Soft Tissue Allografts Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Cartilage Allografts
      • 10.2.1.1. Hyaline Cartilage
      • 10.2.1.2. Elastic Cartilage
      • 10.2.1.3. Fibro Cartilage
    • 10.2.2. Tendon Allografts
      • 10.2.2.1. Achilles Tendon
      • 10.2.2.2. Tibialis
      • 10.2.2.3. Patellar Tendon
      • 10.2.2.4. Hamstring
    • 10.2.3. Dental Allografts
      • 10.2.3.1. Free Gingival Graft
      • 10.2.3.2. Connective Tissue Graft
      • 10.2.3.3. Pedicle Graft
    • 10.2.4. Meniscus Allografts
    • 10.2.5. Collagen Allografts
    • 10.2.6. Amniotic Allografts
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Orthopedics
      • 10.3.1.1. Sports Medicine
      • 10.3.1.2. Spine Surgeries
      • 10.3.1.3. General Orthopedics
      • 10.3.1.4. Reconstruction
    • 10.3.2. Dentistry
      • 10.3.2.1. Dental Sensitivity
      • 10.3.2.2. Aesthetics
    • 10.3.3. Wound Care
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Orthopedic Clinics
    • 10.4.2. Dental Clinics
    • 10.4.3. Ambulatory Surgical Centers
    • 10.4.4. Aesthetic Centers
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Soft Tissue Allografts Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Cartilage Allografts
      • 11.2.1.1. Hyaline Cartilage
      • 11.2.1.2. Elastic Cartilage
      • 11.2.1.3. Fibro Cartilage
    • 11.2.2. Tendon Allografts
      • 11.2.2.1. Achilles Tendon
      • 11.2.2.2. Tibialis
      • 11.2.2.3. Patellar Tendon
      • 11.2.2.4. Hamstring
    • 11.2.3. Dental Allografts
      • 11.2.3.1. Free Gingival Graft
      • 11.2.3.2. Connective Tissue Graft
      • 11.2.3.3. Pedicle Graft
    • 11.2.4. Meniscus Allografts
    • 11.2.5. Collagen Allografts
    • 11.2.6. Amniotic Allografts
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Orthopedics
      • 11.3.1.1. Sports Medicine
      • 11.3.1.2. Spine Surgeries
      • 11.3.1.3. General Orthopedics
      • 11.3.1.4. Reconstruction
    • 11.3.2. Dentistry
      • 11.3.2.1. Dental Sensitivity
      • 11.3.2.2. Aesthetics
    • 11.3.3. Wound Care
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Orthopedic Clinics
    • 11.4.2. Dental Clinics
    • 11.4.3. Ambulatory Surgical Centers
    • 11.4.4. Aesthetic Centers
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Soft Tissue Allografts Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Cartilage Allografts
      • 12.2.1.1. Hyaline Cartilage
      • 12.2.1.2. Elastic Cartilage
      • 12.2.1.3. Fibro Cartilage
    • 12.2.2. Tendon Allografts
      • 12.2.2.1. Achilles Tendon
      • 12.2.2.2. Tibialis
      • 12.2.2.3. Patellar Tendon
      • 12.2.2.4. Hamstring
    • 12.2.3. Dental Allografts
      • 12.2.3.1. Free Gingival Graft
      • 12.2.3.2. Connective Tissue Graft
      • 12.2.3.3. Pedicle Graft
    • 12.2.4. Meniscus Allografts
    • 12.2.5. Collagen Allografts
    • 12.2.6. Amniotic Allografts
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Orthopedics
      • 12.3.1.1. Sports Medicine
      • 12.3.1.2. Spine Surgeries
      • 12.3.1.3. General Orthopedics
      • 12.3.1.4. Reconstruction
    • 12.3.2. Dentistry
      • 12.3.2.1. Dental Sensitivity
      • 12.3.2.2. Aesthetics
    • 12.3.3. Wound Care
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Orthopedic Clinics
    • 12.4.2. Dental Clinics
    • 12.4.3. Ambulatory Surgical Centers
    • 12.4.4. Aesthetic Centers
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Soft Tissue Allografts Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Cartilage Allografts
      • 13.2.1.1. Hyaline Cartilage
      • 13.2.1.2. Elastic Cartilage
      • 13.2.1.3. Fibro Cartilage
    • 13.2.2. Tendon Allografts
      • 13.2.2.1. Achilles Tendon
      • 13.2.2.2. Tibialis
      • 13.2.2.3. Patellar Tendon
      • 13.2.2.4. Hamstring
    • 13.2.3. Dental Allografts
      • 13.2.3.1. Free Gingival Graft
      • 13.2.3.2. Connective Tissue Graft
      • 13.2.3.3. Pedicle Graft
    • 13.2.4. Meniscus Allografts
    • 13.2.5. Collagen Allografts
    • 13.2.6. Amniotic Allografts
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Orthopedics
      • 13.3.1.1. Sports Medicine
      • 13.3.1.2. Spine Surgeries
      • 13.3.1.3. General Orthopedics
      • 13.3.1.4. Reconstruction
    • 13.3.2. Dentistry
      • 13.3.2.1. Dental Sensitivity
      • 13.3.2.2. Aesthetics
    • 13.3.3. Wound Care
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Orthopedic Clinics
    • 13.4.2. Dental Clinics
    • 13.4.3. Ambulatory Surgical Centers
    • 13.4.4. Aesthetic Centers
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Soft Tissue Allografts Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Cartilage Allografts
      • 14.2.1.1. Hyaline Cartilage
      • 14.2.1.2. Elastic Cartilage
      • 14.2.1.3. Fibro Cartilage
    • 14.2.2. Tendon Allografts
      • 14.2.2.1. Achilles Tendon
      • 14.2.2.2. Tibialis
      • 14.2.2.3. Patellar Tendon
      • 14.2.2.4. Hamstring
    • 14.2.3. Dental Allografts
      • 14.2.3.1. Free Gingival Graft
      • 14.2.3.2. Connective Tissue Graft
      • 14.2.3.3. Pedicle Graft
    • 14.2.4. Meniscus Allografts
    • 14.2.5. Collagen Allografts
    • 14.2.6. Amniotic Allografts
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Orthopedics
      • 14.3.1.1. Sports Medicine
      • 14.3.1.2. Spine Surgeries
      • 14.3.1.3. General Orthopedic
      • 14.3.1.4. Reconstruction
    • 14.3.2. Dentistry
      • 14.3.2.1. Dental Sensitivity
      • 14.3.2.2. Aesthetics
    • 14.3.3. Wound Care
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Orthopedic Clinics
    • 14.4.2. Dental Clinics
    • 14.4.3. Ambulatory Surgical Centers
    • 14.4.4. Aesthetic Centers
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Lattice Biologics Ltd
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Zimmer Biomet
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. AlonSource Group
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. MiMedix Group.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. AlloSource.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. CONMED Corporation.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Organogenesis, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. RTI Surgical, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. Osiris Therapeutics.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Integra LifeSciences Corporation.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview
    • 15.3.11. Globus Medical, Inc.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. SWOT Analysis
      • 15.3.11.4. Strategic Overview
    • 15.3.12. B. Braun Melsungen AG.
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. SWOT Analysis
      • 15.3.12.4. Strategic Overview
    • 15.3.13. Arthrex
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. SWOT Analysis
      • 15.3.13.4. Strategic Overview